Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/SC/Myrtle Beach
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Myrtle Beach, SC

Studies commonly pay $75 to $4,500 per completed study

88 clinical trials are currently recruiting participants within 30 miles of Myrtle Beach. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

88studies recruiting
6+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Myrtle Beach right now

Top 25 of 88 recruiting studies, sorted by proximity — each links to its official registry page

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Steba Biotech S.A.
See eligibility & contact on ClinicalTrials.gov (NCT04620239)

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Metastatic Hormone-sensitive Prostate Cancer Phase 2 Interventional 150 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06991556)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 3 Interventional 641 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06319820)

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Non-muscle-invasive Bladder Cancer, NMIBC Phase 1 Interventional 55 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Aura Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT05483868)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
TMA Headlands LLC /ID# 259800 — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06345339)

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Prostate Cancer, Metastatic Castration Resistant Prostate Cancer Phase 1 Interventional 174 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04729114)

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Asthma Phase 3 Interventional 724 participants sought
Teva Investigational Site 12111 — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Teva Branded Pharmaceutical Products R&D LLC
See eligibility & contact on ClinicalTrials.gov (NCT06664619)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Carolina Regional Cancer Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

High-Risk Non-Muscle-Invasive Bladder Cancer Phase 2 Interventional 325 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: CG Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06567743)

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Overweight, Obesity Phase 3 Interventional 900 participants sought
Trial Management Associates — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07392190)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Carolina Regional Cancer Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

Prostate Cancer Phase 1, Phase 2 Interventional 300 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07336446)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Bladder Carcinoma, Ureter Carcinoma N/A Observational 2,020 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Guardant Health, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05059444)

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

Muscle-invasive Bladder Cancer Phase 2 Interventional 240 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07475806)

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Type 2 Diabetes Mellitus Phase 3 Interventional 600 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07664553)

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Non-muscle-invasive Bladder Cancer Phase 1, Phase 2 Interventional 75 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: SURGE Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT05710848)

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase 2 Interventional 400 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Dendreon
See eligibility & contact on ClinicalTrials.gov (NCT06134232)

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC) Phase 1 Interventional 453 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT03460977)

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Phase 3 Interventional 250 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Ferring Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06545955)

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Advanced Renal Cell Carcinoma (RCC) Phase 1, Phase 2 Interventional 474 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07293351)

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking

Tobacco Use, Substance Use Disorders N/A Interventional 240 participants sought
Shoreline Behavioral Health Services — Conway, South Carolina (12.8 mi) · Sponsor: Medical University of South Carolina
See eligibility & contact on ClinicalTrials.gov (NCT06922617)
Actively enrolling

Studies you may be able to join near Myrtle Beach

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Myrtle Beach

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

START Carolinas

★ 4.7
823 82nd Pkwy suite b, Myrtle Beach, SC 29572
(843) 839-1679
"Initial conference for stone removal. Didn’t learn anything I hadn’t already learned from the internet. In a holding pattern for surgery scheduling."
— Happy Jack, 4★

Advanced Clinical Trials

★ 5.0
291 SC-90 #291e, Little River, SC 29566
(843) 249-4129

Body Revolution Aesthetics & Wellness

★ 5.0
1211 48th Ave N, Myrtle Beach, SC 29577
(843) 213-1633

Coastal Carolina Research Center

★ 4.4
4920 O'Hear Ave Ste 101, North Charleston, SC 29405
(843) 856-3784
"I feel Coastal Carolina is a valuable asset to the research community in the Charleston area. They are extremely welcoming and professional. Their ex…"
— Pam, 5★

Little River Medical Center

★ 4.4
4220 Carolina Exchange Dr, Myrtle Beach, SC 29579
(843) 663-8000
"Dr. Insignares is a great face for LRMC. With him, it is all about the patient—like it used to be!"
— ElizabethT, 5★

Clinical Research Center Of The Carolinas

1364 Ashley River Rd, Charleston, SC 29407
(843) 375-8111

Clinical trials in Myrtle Beach: what's recruiting

The Myrtle Beach area currently has 88 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Myrtle Beach, the most active research areas are:

  • Cancer & Oncology18 studies
  • Liver & Kidney3 studies
  • Diabetes & Metabolism2 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Myrtle Beach, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Myrtle Beach

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Myrtle Beach participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Myrtle Beach pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Myrtle Beach, SC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Myrtle Beach?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Myrtle Beach typically complete one or two studies per year.

Paid clinical trials near Myrtle Beach

Other metros within reach

Wilmington, NC111 Fayetteville, NC125 Charleston, SC730 Columbia, SC194 Cary, NC1,669 Raleigh, NC1,661 Durham, NC1,669 Concord, NC624

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Myrtle Beach Bladder Issues Due To Spinal Cord Injury in Myrtle Beach All conditions

More of SC

Charleston730 Rock Hill581 Greenville378 Mauldin376 Spartanburg363 Columbia194

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts